What are the urinary and sexual adverse effects of lorazepam, hydroxyzine, quetiapine, lithium, and bupropion?

Urinary and Sexual Adverse Effects of Lorazepam, Hydroxyzine, Quetiapine, Lithium, and Bupropion

Bupropion stands out as having significantly lower rates of sexual dysfunction compared to other antidepressants, while benzodiazepines like lorazepam combined with lithium are associated with substantial sexual dysfunction, and quetiapine carries notable risks for both sexual and urinary adverse effects.

Lorazepam

Sexual Effects

• Change in libido, impotence, and decreased orgasm are documented adverse reactions 1
• When combined with lithium, sexual dysfunction occurs in approximately 50% of patients, compared to only 14% with lithium alone 2
• The combination of lithium and benzodiazepines shows a significantly higher association with sexual dysfunction than lithium monotherapy or lithium combined with other medications 2

Urinary Effects

• Syndrome of inappropriate antidiuretic hormone (SIADH) and hyponatremia can occur 1
• These effects can indirectly impact urinary function through electrolyte disturbances 1

Clinical Pitfall: The sexual dysfunction associated with lorazepam is particularly pronounced when combined with lithium, yet this combination is commonly prescribed in bipolar disorder management. Consider alternative anxiolytics if sexual function is a priority 2.

Hydroxyzine

Sexual and Urinary Effects

• Antihistamines, including hydroxyzine, may impair erectile function through anticholinergic mechanisms 3
• The evidence base is limited, but as an antihistamine with anticholinergic properties, hydroxyzine can contribute to sexual dysfunction 3
• Urinary retention may occur due to anticholinergic effects, though specific data for hydroxyzine is sparse 4

Quetiapine

Sexual Effects

• Sexual dysfunction occurs in 18.2% of patients in clinical studies, which is lower than haloperidol (38.1%) and risperidone (43.2%), but still clinically significant 5
• Recent pharmacovigilance data suggests quetiapine has higher risk signals across multiple sexual adverse events 6
• The mechanism involves prolactin elevation, dopamine blockade, and anticholinergic effects 5, 6
• Sexual dysfunction appears dose-related with quetiapine 5
• During short-term treatment (<12 weeks), quetiapine shows lower risk compared to other antipsychotics, but long-term data is lacking 5

Urinary Effects

• Nocturnal enuresis has been reported in post-marketing surveillance 7
• This represents a specific urinary adverse effect that can significantly impact quality of life, particularly in younger patients 7

Clinical Consideration: Among atypical antipsychotics, quetiapine has the highest central anticholinergic activity alongside clozapine and olanzapine, which contributes to both sexual and urinary adverse effects 8.

Lithium

Sexual Effects

• Lithium alone appears to have minimal effect on sexual function, with only 14% of patients reporting sexual dysfunction on monotherapy 2
• However, when combined with benzodiazepines, sexual dysfunction increases dramatically to 49% of patients 2
• No relationship exists between serum lithium levels or plasma prolactin levels and sexual dysfunction scores 2
• The mechanism of sexual dysfunction with lithium combinations is not fully understood but may involve additive effects on neurotransmitter systems 2

Urinary Effects

• Lithium can cause polyuria and polydipsia through effects on renal concentrating ability (not explicitly detailed in provided evidence but well-established clinically)
• The evidence provided does not detail specific urinary adverse effects beyond general monitoring recommendations 9

Bupropion

Sexual Effects

• Bupropion has significantly lower rates of sexual adverse events compared to SSRIs like fluoxetine and sertraline 10
• Sexual dysfunction occurs in less than 10% of patients taking bupropion 11
• This represents a 3-6 fold lower rate compared to SSRIs (30-60% incidence) 11
• Bupropion is specifically recommended when sexual dysfunction is a concern, as it does not cause the serotonergic-mediated sexual side effects common with SSRIs 10

Urinary Effects

• The provided evidence does not document specific urinary adverse effects with bupropion
• Bupropion's activating properties may indirectly affect urinary patterns through increased sympathetic tone, but this is not well-documented 9

Clinical Advantage: Bupropion should be the preferred antidepressant when sexual function is a priority, particularly in patients who have experienced sexual dysfunction with SSRIs 10, 11.

Comparative Risk Profile

Sexual Dysfunction Ranking (Highest to Lowest Risk):

1. Lorazepam + Lithium combination: ~50% incidence 2
2. Quetiapine: 18.2% (short-term), potentially higher long-term 5, 6
3. Lithium monotherapy: 14% incidence 2
4. Bupropion: <10% incidence 11
5. Hydroxyzine: Limited data, but anticholinergic effects suggest moderate risk 3

Urinary Dysfunction Considerations:

• Quetiapine: Documented nocturnal enuresis risk 7
• Lorazepam: SIADH and hyponatremia risk 1
• Hydroxyzine: Theoretical anticholinergic-mediated urinary retention 4
• Lithium and Bupropion: Minimal documented urinary effects in provided evidence

Management Strategies

For Sexual Dysfunction:

• Avoid combining lithium with benzodiazepines when possible; if anxiolysis is needed, consider alternatives 2
• Choose bupropion over SSRIs as first-line antidepressant when sexual function is a concern 10, 11
• Monitor quetiapine dosing as sexual dysfunction is dose-related; use lowest effective dose 5
• Consider switching from quetiapine to aripiprazole if sexual dysfunction develops, as aripiprazole has lower anticholinergic burden 8

For Urinary Effects:

• Monitor for nocturnal enuresis in patients on quetiapine, particularly children and adolescents 7
• Check electrolytes regularly in patients on lorazepam due to SIADH risk 1
• Minimize anticholinergic burden by avoiding combinations of hydroxyzine with other anticholinergic medications 8